←Back to Expert Scholars
Translational Medicine / 转化医学Colorectal ctDNA Early Stage
Minetta Liu
MD
🏢Natera🌐USA
Chief Medical Officer
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Minetta Liu is chief medical officer at Natera and oversees development of the Signatera ctDNA MRD assay. She has led clinical validation studies across tumor types including colorectal cancer. Her work supports integration of tumor informed ctDNA testing into routine oncology practice. She previously led breast cancer research at Mayo Clinic.
Share:
🧪Research Fields 研究领域
circulating tumor DNA
minimal residual disease
breast cancer
colorectal cancer
clinical development
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Minetta Liu 的研究动态
Follow Minetta Liu's research updates
留下邮箱，当我们发布与 Minetta Liu（Natera）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment